Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance
MH Sherman, GL Beatty - Annual Review of Pathology …, 2023 - annualreviews.org
Pancreatic ductal adenocarcinoma (PDAC) features a prominent stromal microenvironment
with remarkable cellular and spatial heterogeneity that meaningfully impacts disease …
with remarkable cellular and spatial heterogeneity that meaningfully impacts disease …
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
The functions of, and interactions between, the innate and adaptive immune systems are
vital for anticancer immunity. Cytotoxic T cells expressing cell-surface CD8 are the most …
vital for anticancer immunity. Cytotoxic T cells expressing cell-surface CD8 are the most …
Recent advances in tumor targeting via EPR effect for cancer treatment
Cancer causes the second-highest rate of death world-wide. A major shortcoming inherent
in most of anticancer drugs is their lack of tumor selectivity. Nanodrugs for cancer therapy …
in most of anticancer drugs is their lack of tumor selectivity. Nanodrugs for cancer therapy …
Targeting hypoxic tumor microenvironment in pancreatic cancer
J Tao, G Yang, W Zhou, J Qiu, G Chen, W Luo… - Journal of hematology & …, 2021 - Springer
Attributable to its late diagnosis, early metastasis, and poor prognosis, pancreatic cancer
remains one of the most lethal diseases worldwide. Unlike other solid tumors, pancreatic …
remains one of the most lethal diseases worldwide. Unlike other solid tumors, pancreatic …
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Y Cheng, C He, M Wang, X Ma, F Mo, S Yang… - Signal transduction and …, 2019 - nature.com
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …
Stem cell fate in cancer growth, progression and therapy resistance
Although we have come a long way in our understanding of the signals that drive cancer
growth, and how these signals can be targeted, effective control of this disease remains a …
growth, and how these signals can be targeted, effective control of this disease remains a …
Dissecting metastasis using preclinical models and methods
Metastasis has long been understood to lead to the overwhelming majority of cancer-related
deaths. However, our understanding of the metastatic process, and thus our ability to …
deaths. However, our understanding of the metastatic process, and thus our ability to …
[HTML][HTML] Regulation of pH by carbonic anhydrase 9 mediates survival of pancreatic cancer cells with activated KRAS in response to hypoxia
Background & Aims Most pancreatic ductal adenocarcinomas (PDACs) express an activated
form of KRAS, become hypoxic and dysplastic, and are refractory to chemo and radiation …
form of KRAS, become hypoxic and dysplastic, and are refractory to chemo and radiation …
Resha** the tumor stroma for treatment of pancreatic cancer
Pancreatic cancer is accompanied by a fibrotic reaction that alters interactions between
tumor cells and the stroma to promote tumor progression. Consequently, strategies to target …
tumor cells and the stroma to promote tumor progression. Consequently, strategies to target …
The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma
T Evan, VMY Wang, A Behrens - Oncogene, 2022 - nature.com
Intratumour heterogeneity (ITH) has become an important focus of cancer research in recent
years. ITH describes the cellular variation that enables tumour evolution, including tumour …
years. ITH describes the cellular variation that enables tumour evolution, including tumour …